Institutional members access full text with Ovid®

Share this article on:

Lipoprotein abnormalities in patients with type 2 diabetes and metabolic syndrome

Dickson-Humphries, Tania MPAS, PA-C; Bottenberg, B. DO, FACOI, FNLA; Kuntz, Susan PhD

Journal of the American Academy of PAs: July 2013 - Volume 26 - Issue 7 - p 13–18
doi: 10.1097/01.JAA.0000431506.00627.be
Cardiovascular Medicine

ABSTRACT Cardiovascular disease remains the leading cause of death in men and women in the United States. Aggressive treatment of insulin resistance and its associated lipid abnormalities remains a top priority for preventing cardiovascular morbidity and mortality.

Tania Dickson-Humphries is a PA in vascular surgery for Carson Surgical Group in Carson City, Nevada, and a recent graduate of the University of North Dakota PA program. B. Bottenberg practices internal medicine and lipidology in Carson City, Nevada, and is president-elect of the Pacific Lipid Association. Susan Kuntz is an assistant professor in the department of family and community medicine in the PA program at the University of North Dakota at Grand Forks. The authors have indicated no relationships to disclose relating to the content of this article.

Earn Category I CME credit by reading this article and the article beginning on page 20 and successfully completing the posttest on page 28. Successful completion is defined as a cumulative score of at least 70% correct. This material has been reviewed and is approved for 1 hour of clinical Category I (Preapproved) CME credit by the AAPA. The term of approval is for 1 year from the publication date of July 2013.

© 2013 American Academy of Physician Assistants.
You currently do not have access to this article

To access this article:

Note: If your society membership provides full-access, you may need to login on your society website